nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA6—ear—germ cell cancer	0.0434	0.119	CbGeAlD
Brinzolamide—CA4—ganglion—germ cell cancer	0.0112	0.0307	CbGeAlD
Brinzolamide—CA5A—endocrine gland—germ cell cancer	0.0102	0.028	CbGeAlD
Brinzolamide—CA14—telencephalon—germ cell cancer	0.00894	0.0246	CbGeAlD
Brinzolamide—CYP3A4—urine—germ cell cancer	0.00879	0.0241	CbGeAlD
Brinzolamide—CA7—midbrain—germ cell cancer	0.00771	0.0212	CbGeAlD
Brinzolamide—CA12—eye—germ cell cancer	0.00765	0.021	CbGeAlD
Brinzolamide—CA14—medulla oblongata—germ cell cancer	0.00703	0.0193	CbGeAlD
Brinzolamide—CA12—telencephalon—germ cell cancer	0.00697	0.0192	CbGeAlD
Brinzolamide—CA14—adrenal gland—germ cell cancer	0.0065	0.0179	CbGeAlD
Brinzolamide—CA6—head—germ cell cancer	0.00648	0.0178	CbGeAlD
Brinzolamide—CA14—midbrain—germ cell cancer	0.00642	0.0176	CbGeAlD
Brinzolamide—CA4—neck—germ cell cancer	0.00637	0.0175	CbGeAlD
Brinzolamide—CA14—spinal cord—germ cell cancer	0.00627	0.0172	CbGeAlD
Brinzolamide—CA1—eye—germ cell cancer	0.00606	0.0166	CbGeAlD
Brinzolamide—CA7—cerebellum—germ cell cancer	0.00596	0.0164	CbGeAlD
Brinzolamide—CA9—endocrine gland—germ cell cancer	0.00595	0.0163	CbGeAlD
Brinzolamide—CA9—testis—germ cell cancer	0.00567	0.0156	CbGeAlD
Brinzolamide—CA1—telencephalon—germ cell cancer	0.00552	0.0152	CbGeAlD
Brinzolamide—CA2—neck—germ cell cancer	0.00528	0.0145	CbGeAlD
Brinzolamide—CA9—cerebellum—germ cell cancer	0.00524	0.0144	CbGeAlD
Brinzolamide—CA5B—gonad—germ cell cancer	0.00522	0.0143	CbGeAlD
Brinzolamide—CA14—cerebellum—germ cell cancer	0.00497	0.0136	CbGeAlD
Brinzolamide—CA4—brainstem—germ cell cancer	0.00487	0.0134	CbGeAlD
Brinzolamide—CA7—brain—germ cell cancer	0.00484	0.0133	CbGeAlD
Brinzolamide—CA2—trigeminal ganglion—germ cell cancer	0.00456	0.0125	CbGeAlD
Brinzolamide—CA5B—adrenal gland—germ cell cancer	0.00455	0.0125	CbGeAlD
Brinzolamide—CA2—embryo—germ cell cancer	0.0044	0.0121	CbGeAlD
Brinzolamide—CA12—endocrine gland—germ cell cancer	0.0044	0.0121	CbGeAlD
Brinzolamide—CA12—head—germ cell cancer	0.00434	0.0119	CbGeAlD
Brinzolamide—CA4—telencephalon—germ cell cancer	0.00432	0.0119	CbGeAlD
Brinzolamide—CA14—brain—germ cell cancer	0.00404	0.0111	CbGeAlD
Brinzolamide—CA2—brainstem—germ cell cancer	0.00403	0.0111	CbGeAlD
Brinzolamide—CA5B—endocrine gland—germ cell cancer	0.00395	0.0108	CbGeAlD
Brinzolamide—CA2—eye—germ cell cancer	0.00393	0.0108	CbGeAlD
Brinzolamide—CA5B—head—germ cell cancer	0.0039	0.0107	CbGeAlD
Brinzolamide—CA2—retina—germ cell cancer	0.00389	0.0107	CbGeAlD
Brinzolamide—CA1—bone marrow—germ cell cancer	0.00389	0.0107	CbGeAlD
Brinzolamide—CA1—spinal cord—germ cell cancer	0.00387	0.0106	CbGeAlD
Brinzolamide—CA5B—testis—germ cell cancer	0.00376	0.0103	CbGeAlD
Brinzolamide—CA2—telencephalon—germ cell cancer	0.00358	0.00983	CbGeAlD
Brinzolamide—CA4—pituitary gland—germ cell cancer	0.00352	0.00965	CbGeAlD
Brinzolamide—CA1—endocrine gland—germ cell cancer	0.00348	0.00957	CbGeAlD
Brinzolamide—CA1—head—germ cell cancer	0.00344	0.00945	CbGeAlD
Brinzolamide—CA2—skin of body—germ cell cancer	0.00342	0.00938	CbGeAlD
Brinzolamide—CA2—decidua—germ cell cancer	0.00339	0.00932	CbGeAlD
Brinzolamide—CA4—medulla oblongata—germ cell cancer	0.00339	0.00932	CbGeAlD
Brinzolamide—CA12—brain—germ cell cancer	0.00315	0.00864	CbGeAlD
Brinzolamide—CA4—adrenal gland—germ cell cancer	0.00314	0.00863	CbGeAlD
Brinzolamide—CA4—midbrain—germ cell cancer	0.0031	0.00852	CbGeAlD
Brinzolamide—CA4—bone marrow—germ cell cancer	0.00304	0.00834	CbGeAlD
Brinzolamide—CA4—spinal cord—germ cell cancer	0.00303	0.00831	CbGeAlD
Brinzolamide—CA4—female gonad—germ cell cancer	0.00293	0.00804	CbGeAlD
Brinzolamide—CA2—pituitary gland—germ cell cancer	0.00292	0.00801	CbGeAlD
Brinzolamide—CA5B—brain—germ cell cancer	0.00282	0.00775	CbGeAlD
Brinzolamide—CA2—medulla oblongata—germ cell cancer	0.00281	0.00773	CbGeAlD
Brinzolamide—CA5B—lymph node—germ cell cancer	0.00273	0.00749	CbGeAlD
Brinzolamide—CA4—endocrine gland—germ cell cancer	0.00272	0.00748	CbGeAlD
Brinzolamide—CA4—head—germ cell cancer	0.00269	0.00738	CbGeAlD
Brinzolamide—CA2—adrenal gland—germ cell cancer	0.0026	0.00715	CbGeAlD
Brinzolamide—CA4—testis—germ cell cancer	0.0026	0.00713	CbGeAlD
Brinzolamide—Eye disorder—Ifosfamide—germ cell cancer	0.00258	0.00406	CcSEcCtD
Brinzolamide—Conjunctivitis—Cisplatin—germ cell cancer	0.00258	0.00406	CcSEcCtD
Brinzolamide—Tinnitus—Ifosfamide—germ cell cancer	0.00258	0.00405	CcSEcCtD
Brinzolamide—CA2—midbrain—germ cell cancer	0.00257	0.00706	CbGeAlD
Brinzolamide—Cardiac disorder—Ifosfamide—germ cell cancer	0.00256	0.00403	CcSEcCtD
Brinzolamide—Malaise—Bleomycin—germ cell cancer	0.00254	0.00399	CcSEcCtD
Brinzolamide—CA2—bone marrow—germ cell cancer	0.00252	0.00692	CbGeAlD
Brinzolamide—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00251	0.00395	CcSEcCtD
Brinzolamide—CA2—spinal cord—germ cell cancer	0.00251	0.00689	CbGeAlD
Brinzolamide—Angiopathy—Ifosfamide—germ cell cancer	0.00251	0.00394	CcSEcCtD
Brinzolamide—Immune system disorder—Ifosfamide—germ cell cancer	0.0025	0.00393	CcSEcCtD
Brinzolamide—CA1—brain—germ cell cancer	0.00249	0.00685	CbGeAlD
Brinzolamide—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00249	0.00392	CcSEcCtD
Brinzolamide—Arrhythmia—Ifosfamide—germ cell cancer	0.00247	0.00388	CcSEcCtD
Brinzolamide—Cough—Bleomycin—germ cell cancer	0.00246	0.00386	CcSEcCtD
Brinzolamide—Paraesthesia—Vinblastine—germ cell cancer	0.00244	0.00384	CcSEcCtD
Brinzolamide—Alopecia—Ifosfamide—germ cell cancer	0.00244	0.00384	CcSEcCtD
Brinzolamide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00244	0.00383	CcSEcCtD
Brinzolamide—Infestation—Etoposide—germ cell cancer	0.00243	0.00382	CcSEcCtD
Brinzolamide—Infestation NOS—Etoposide—germ cell cancer	0.00243	0.00382	CcSEcCtD
Brinzolamide—CA2—female gonad—germ cell cancer	0.00243	0.00667	CbGeAlD
Brinzolamide—Bradycardia—Cisplatin—germ cell cancer	0.00243	0.00381	CcSEcCtD
Brinzolamide—Mental disorder—Ifosfamide—germ cell cancer	0.00242	0.00381	CcSEcCtD
Brinzolamide—CA1—lymph node—germ cell cancer	0.00241	0.00661	CbGeAlD
Brinzolamide—Erythema—Ifosfamide—germ cell cancer	0.00241	0.00378	CcSEcCtD
Brinzolamide—Malnutrition—Ifosfamide—germ cell cancer	0.00241	0.00378	CcSEcCtD
Brinzolamide—CA4—cerebellum—germ cell cancer	0.0024	0.00659	CbGeAlD
Brinzolamide—Chest pain—Bleomycin—germ cell cancer	0.0024	0.00377	CcSEcCtD
Brinzolamide—Myalgia—Bleomycin—germ cell cancer	0.0024	0.00377	CcSEcCtD
Brinzolamide—Discomfort—Bleomycin—germ cell cancer	0.00237	0.00372	CcSEcCtD
Brinzolamide—Malaise—Dactinomycin—germ cell cancer	0.00237	0.00372	CcSEcCtD
Brinzolamide—Decreased appetite—Vinblastine—germ cell cancer	0.00236	0.00372	CcSEcCtD
Brinzolamide—Urinary tract disorder—Cisplatin—germ cell cancer	0.00235	0.0037	CcSEcCtD
Brinzolamide—Connective tissue disorder—Cisplatin—germ cell cancer	0.00234	0.00368	CcSEcCtD
Brinzolamide—Urethral disorder—Cisplatin—germ cell cancer	0.00234	0.00367	CcSEcCtD
Brinzolamide—Pain—Vinblastine—germ cell cancer	0.00233	0.00366	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Etoposide—germ cell cancer	0.0023	0.00362	CcSEcCtD
Brinzolamide—Visual impairment—Cisplatin—germ cell cancer	0.0023	0.00361	CcSEcCtD
Brinzolamide—Infection—Bleomycin—germ cell cancer	0.00228	0.00359	CcSEcCtD
Brinzolamide—Vision blurred—Ifosfamide—germ cell cancer	0.00227	0.00357	CcSEcCtD
Brinzolamide—CA2—endocrine gland—germ cell cancer	0.00226	0.0062	CbGeAlD
Brinzolamide—Feeling abnormal—Vinblastine—germ cell cancer	0.00224	0.00353	CcSEcCtD
Brinzolamide—Myalgia—Dactinomycin—germ cell cancer	0.00224	0.00352	CcSEcCtD
Brinzolamide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00223	0.00351	CcSEcCtD
Brinzolamide—CA2—head—germ cell cancer	0.00223	0.00612	CbGeAlD
Brinzolamide—Eye disorder—Cisplatin—germ cell cancer	0.00223	0.0035	CcSEcCtD
Brinzolamide—Tinnitus—Cisplatin—germ cell cancer	0.00222	0.00349	CcSEcCtD
Brinzolamide—Cardiac disorder—Cisplatin—germ cell cancer	0.00221	0.00348	CcSEcCtD
Brinzolamide—Agitation—Ifosfamide—germ cell cancer	0.00221	0.00348	CcSEcCtD
Brinzolamide—Discomfort—Dactinomycin—germ cell cancer	0.00221	0.00347	CcSEcCtD
Brinzolamide—Hypoaesthesia—Etoposide—germ cell cancer	0.00217	0.00342	CcSEcCtD
Brinzolamide—Malaise—Ifosfamide—germ cell cancer	0.00217	0.00341	CcSEcCtD
Brinzolamide—Vertigo—Ifosfamide—germ cell cancer	0.00216	0.0034	CcSEcCtD
Brinzolamide—Urinary tract disorder—Etoposide—germ cell cancer	0.00216	0.00339	CcSEcCtD
Brinzolamide—CA2—testis—germ cell cancer	0.00215	0.00591	CbGeAlD
Brinzolamide—Immune system disorder—Cisplatin—germ cell cancer	0.00215	0.00338	CcSEcCtD
Brinzolamide—Mediastinal disorder—Cisplatin—germ cell cancer	0.00215	0.00338	CcSEcCtD
Brinzolamide—Hypotension—Bleomycin—germ cell cancer	0.00215	0.00338	CcSEcCtD
Brinzolamide—Urethral disorder—Etoposide—germ cell cancer	0.00214	0.00337	CcSEcCtD
Brinzolamide—Infection—Dactinomycin—germ cell cancer	0.00213	0.00335	CcSEcCtD
Brinzolamide—Arrhythmia—Cisplatin—germ cell cancer	0.00213	0.00335	CcSEcCtD
Brinzolamide—Palpitations—Ifosfamide—germ cell cancer	0.00213	0.00334	CcSEcCtD
Brinzolamide—Alopecia—Cisplatin—germ cell cancer	0.00211	0.00331	CcSEcCtD
Brinzolamide—Cough—Ifosfamide—germ cell cancer	0.0021	0.0033	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00209	0.00329	CcSEcCtD
Brinzolamide—Hypertension—Ifosfamide—germ cell cancer	0.00208	0.00327	CcSEcCtD
Brinzolamide—Erythema—Cisplatin—germ cell cancer	0.00207	0.00326	CcSEcCtD
Brinzolamide—Malnutrition—Cisplatin—germ cell cancer	0.00207	0.00326	CcSEcCtD
Brinzolamide—Paraesthesia—Bleomycin—germ cell cancer	0.00206	0.00324	CcSEcCtD
Brinzolamide—Dyspnoea—Bleomycin—germ cell cancer	0.00205	0.00322	CcSEcCtD
Brinzolamide—Arthralgia—Ifosfamide—germ cell cancer	0.00205	0.00322	CcSEcCtD
Brinzolamide—Chest pain—Ifosfamide—germ cell cancer	0.00205	0.00322	CcSEcCtD
Brinzolamide—Myalgia—Ifosfamide—germ cell cancer	0.00205	0.00322	CcSEcCtD
Brinzolamide—Flatulence—Cisplatin—germ cell cancer	0.00204	0.00321	CcSEcCtD
Brinzolamide—Eye disorder—Etoposide—germ cell cancer	0.00204	0.00321	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00203	0.0032	CcSEcCtD
Brinzolamide—Cardiac disorder—Etoposide—germ cell cancer	0.00203	0.00319	CcSEcCtD
Brinzolamide—Discomfort—Ifosfamide—germ cell cancer	0.00202	0.00318	CcSEcCtD
Brinzolamide—Hypersensitivity—Vinblastine—germ cell cancer	0.002	0.00315	CcSEcCtD
Brinzolamide—Decreased appetite—Bleomycin—germ cell cancer	0.002	0.00314	CcSEcCtD
Brinzolamide—Visual disturbance—Methotrexate—germ cell cancer	0.00199	0.00314	CcSEcCtD
Brinzolamide—Muscle spasms—Cisplatin—germ cell cancer	0.00199	0.00314	CcSEcCtD
Brinzolamide—CA2—cerebellum—germ cell cancer	0.00199	0.00546	CbGeAlD
Brinzolamide—Angiopathy—Etoposide—germ cell cancer	0.00198	0.00311	CcSEcCtD
Brinzolamide—Immune system disorder—Etoposide—germ cell cancer	0.00197	0.0031	CcSEcCtD
Brinzolamide—Mediastinal disorder—Etoposide—germ cell cancer	0.00197	0.00309	CcSEcCtD
Brinzolamide—Pain—Bleomycin—germ cell cancer	0.00196	0.00309	CcSEcCtD
Brinzolamide—Vision blurred—Cisplatin—germ cell cancer	0.00195	0.00307	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00195	0.00307	CcSEcCtD
Brinzolamide—Asthenia—Vinblastine—germ cell cancer	0.00195	0.00307	CcSEcCtD
Brinzolamide—Infection—Ifosfamide—germ cell cancer	0.00195	0.00307	CcSEcCtD
Brinzolamide—CA4—brain—germ cell cancer	0.00195	0.00535	CbGeAlD
Brinzolamide—Tremor—Cisplatin—germ cell cancer	0.00194	0.00306	CcSEcCtD
Brinzolamide—Alopecia—Etoposide—germ cell cancer	0.00193	0.00303	CcSEcCtD
Brinzolamide—Nervous system disorder—Ifosfamide—germ cell cancer	0.00193	0.00303	CcSEcCtD
Brinzolamide—Ill-defined disorder—Cisplatin—germ cell cancer	0.00192	0.00303	CcSEcCtD
Brinzolamide—Skin disorder—Ifosfamide—germ cell cancer	0.00191	0.003	CcSEcCtD
Brinzolamide—Feeling abnormal—Bleomycin—germ cell cancer	0.00189	0.00298	CcSEcCtD
Brinzolamide—CA4—lymph node—germ cell cancer	0.00188	0.00517	CbGeAlD
Brinzolamide—Malaise—Cisplatin—germ cell cancer	0.00187	0.00294	CcSEcCtD
Brinzolamide—Decreased appetite—Dactinomycin—germ cell cancer	0.00186	0.00293	CcSEcCtD
Brinzolamide—Diarrhoea—Vinblastine—germ cell cancer	0.00186	0.00293	CcSEcCtD
Brinzolamide—Dysgeusia—Etoposide—germ cell cancer	0.00186	0.00293	CcSEcCtD
Brinzolamide—Fatigue—Dactinomycin—germ cell cancer	0.00185	0.00291	CcSEcCtD
Brinzolamide—Back pain—Etoposide—germ cell cancer	0.00184	0.00289	CcSEcCtD
Brinzolamide—Hypotension—Ifosfamide—germ cell cancer	0.00183	0.00289	CcSEcCtD
Brinzolamide—Pain—Dactinomycin—germ cell cancer	0.00183	0.00288	CcSEcCtD
Brinzolamide—Muscle spasms—Etoposide—germ cell cancer	0.00183	0.00287	CcSEcCtD
Brinzolamide—Urticaria—Bleomycin—germ cell cancer	0.00183	0.00287	CcSEcCtD
Brinzolamide—Irritability—Methotrexate—germ cell cancer	0.0018	0.00284	CcSEcCtD
Brinzolamide—Dizziness—Vinblastine—germ cell cancer	0.0018	0.00283	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00179	0.00281	CcSEcCtD
Brinzolamide—Myalgia—Cisplatin—germ cell cancer	0.00177	0.00278	CcSEcCtD
Brinzolamide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00177	0.00278	CcSEcCtD
Brinzolamide—Paraesthesia—Ifosfamide—germ cell cancer	0.00176	0.00277	CcSEcCtD
Brinzolamide—Ill-defined disorder—Etoposide—germ cell cancer	0.00176	0.00277	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00175	0.00276	CcSEcCtD
Brinzolamide—Dyspnoea—Ifosfamide—germ cell cancer	0.00175	0.00275	CcSEcCtD
Brinzolamide—Somnolence—Ifosfamide—germ cell cancer	0.00175	0.00275	CcSEcCtD
Brinzolamide—Liver function test abnormal—Methotrexate—germ cell cancer	0.00174	0.00274	CcSEcCtD
Brinzolamide—Discomfort—Cisplatin—germ cell cancer	0.00174	0.00274	CcSEcCtD
Brinzolamide—Vomiting—Vinblastine—germ cell cancer	0.00173	0.00272	CcSEcCtD
Brinzolamide—Malaise—Etoposide—germ cell cancer	0.00171	0.00269	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—germ cell cancer	0.00171	0.00269	CcSEcCtD
Brinzolamide—Vertigo—Etoposide—germ cell cancer	0.00171	0.00268	CcSEcCtD
Brinzolamide—Decreased appetite—Ifosfamide—germ cell cancer	0.00171	0.00268	CcSEcCtD
Brinzolamide—Headache—Vinblastine—germ cell cancer	0.0017	0.00268	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.0017	0.00267	CcSEcCtD
Brinzolamide—Fatigue—Ifosfamide—germ cell cancer	0.00169	0.00266	CcSEcCtD
Brinzolamide—Hypersensitivity—Bleomycin—germ cell cancer	0.00169	0.00266	CcSEcCtD
Brinzolamide—Infection—Cisplatin—germ cell cancer	0.00168	0.00264	CcSEcCtD
Brinzolamide—Pain—Ifosfamide—germ cell cancer	0.00168	0.00264	CcSEcCtD
Brinzolamide—Nervous system disorder—Cisplatin—germ cell cancer	0.00166	0.00261	CcSEcCtD
Brinzolamide—Cough—Etoposide—germ cell cancer	0.00166	0.00261	CcSEcCtD
Brinzolamide—Tachycardia—Cisplatin—germ cell cancer	0.00165	0.0026	CcSEcCtD
Brinzolamide—Asthenia—Bleomycin—germ cell cancer	0.00165	0.00259	CcSEcCtD
Brinzolamide—Skin disorder—Cisplatin—germ cell cancer	0.00164	0.00259	CcSEcCtD
Brinzolamide—Hypertension—Etoposide—germ cell cancer	0.00164	0.00258	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—germ cell cancer	0.00163	0.00257	CcSEcCtD
Brinzolamide—Pruritus—Bleomycin—germ cell cancer	0.00163	0.00256	CcSEcCtD
Brinzolamide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00162	0.00254	CcSEcCtD
Brinzolamide—Chest pain—Etoposide—germ cell cancer	0.00162	0.00254	CcSEcCtD
Brinzolamide—CA2—brain—germ cell cancer	0.00162	0.00444	CbGeAlD
Brinzolamide—Nausea—Vinblastine—germ cell cancer	0.00162	0.00254	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00161	0.00253	CcSEcCtD
Brinzolamide—Discomfort—Etoposide—germ cell cancer	0.0016	0.00251	CcSEcCtD
Brinzolamide—Hypotension—Cisplatin—germ cell cancer	0.00158	0.00249	CcSEcCtD
Brinzolamide—Hypersensitivity—Dactinomycin—germ cell cancer	0.00158	0.00248	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—germ cell cancer	0.00157	0.00246	CcSEcCtD
Brinzolamide—CA2—lymph node—germ cell cancer	0.00156	0.00429	CbGeAlD
Brinzolamide—Urticaria—Ifosfamide—germ cell cancer	0.00156	0.00245	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00154	0.00243	CcSEcCtD
Brinzolamide—Infection—Etoposide—germ cell cancer	0.00154	0.00242	CcSEcCtD
Brinzolamide—Asthenia—Dactinomycin—germ cell cancer	0.00154	0.00242	CcSEcCtD
Brinzolamide—Paraesthesia—Cisplatin—germ cell cancer	0.00152	0.00239	CcSEcCtD
Brinzolamide—Tachycardia—Etoposide—germ cell cancer	0.00151	0.00238	CcSEcCtD
Brinzolamide—Dyspnoea—Cisplatin—germ cell cancer	0.00151	0.00237	CcSEcCtD
Brinzolamide—Skin disorder—Etoposide—germ cell cancer	0.00151	0.00237	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—germ cell cancer	0.0015	0.00237	CcSEcCtD
Brinzolamide—Decreased appetite—Cisplatin—germ cell cancer	0.00147	0.00231	CcSEcCtD
Brinzolamide—Diarrhoea—Dactinomycin—germ cell cancer	0.00147	0.00231	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00146	0.0023	CcSEcCtD
Brinzolamide—Vomiting—Bleomycin—germ cell cancer	0.00146	0.0023	CcSEcCtD
Brinzolamide—CYP3A4—endocrine gland—germ cell cancer	0.00146	0.004	CbGeAlD
Brinzolamide—Infestation NOS—Methotrexate—germ cell cancer	0.00146	0.00229	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—germ cell cancer	0.00146	0.00229	CcSEcCtD
Brinzolamide—Depression—Methotrexate—germ cell cancer	0.00145	0.00228	CcSEcCtD
Brinzolamide—Hypotension—Etoposide—germ cell cancer	0.00145	0.00228	CcSEcCtD
Brinzolamide—Rash—Bleomycin—germ cell cancer	0.00145	0.00228	CcSEcCtD
Brinzolamide—Pain—Cisplatin—germ cell cancer	0.00145	0.00228	CcSEcCtD
Brinzolamide—Dermatitis—Bleomycin—germ cell cancer	0.00145	0.00228	CcSEcCtD
Brinzolamide—Hypersensitivity—Ifosfamide—germ cell cancer	0.00145	0.00228	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—germ cell cancer	0.00142	0.00223	CcSEcCtD
Brinzolamide—Asthenia—Ifosfamide—germ cell cancer	0.00141	0.00222	CcSEcCtD
Brinzolamide—Feeling abnormal—Cisplatin—germ cell cancer	0.00139	0.00219	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—germ cell cancer	0.00139	0.00219	CcSEcCtD
Brinzolamide—Pruritus—Ifosfamide—germ cell cancer	0.00139	0.00218	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—germ cell cancer	0.00138	0.00217	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—germ cell cancer	0.00138	0.00217	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00138	0.00217	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—germ cell cancer	0.00137	0.00216	CcSEcCtD
Brinzolamide—Nausea—Bleomycin—germ cell cancer	0.00136	0.00215	CcSEcCtD
Brinzolamide—Vomiting—Dactinomycin—germ cell cancer	0.00136	0.00214	CcSEcCtD
Brinzolamide—Rash—Dactinomycin—germ cell cancer	0.00135	0.00212	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—germ cell cancer	0.00135	0.00212	CcSEcCtD
Brinzolamide—Diarrhoea—Ifosfamide—germ cell cancer	0.00134	0.00211	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00134	0.00211	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—germ cell cancer	0.00134	0.0021	CcSEcCtD
Brinzolamide—Pain—Etoposide—germ cell cancer	0.00133	0.00209	CcSEcCtD
Brinzolamide—Dizziness—Ifosfamide—germ cell cancer	0.0013	0.00204	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—germ cell cancer	0.0013	0.00204	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—germ cell cancer	0.00129	0.00203	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—germ cell cancer	0.00128	0.00202	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—germ cell cancer	0.00128	0.00201	CcSEcCtD
Brinzolamide—Nausea—Dactinomycin—germ cell cancer	0.00127	0.002	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—germ cell cancer	0.00126	0.00198	CcSEcCtD
Brinzolamide—Vomiting—Ifosfamide—germ cell cancer	0.00125	0.00196	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—germ cell cancer	0.00125	0.00196	CcSEcCtD
Brinzolamide—Rash—Ifosfamide—germ cell cancer	0.00124	0.00195	CcSEcCtD
Brinzolamide—Dermatitis—Ifosfamide—germ cell cancer	0.00124	0.00195	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—germ cell cancer	0.00123	0.00194	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—germ cell cancer	0.00122	0.00192	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—germ cell cancer	0.00122	0.00192	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—germ cell cancer	0.00121	0.00191	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—germ cell cancer	0.00121	0.00191	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—germ cell cancer	0.00119	0.00187	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—germ cell cancer	0.00118	0.00186	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—germ cell cancer	0.00118	0.00185	CcSEcCtD
Brinzolamide—Nausea—Ifosfamide—germ cell cancer	0.00117	0.00183	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—germ cell cancer	0.00116	0.00182	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—germ cell cancer	0.00116	0.00182	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—germ cell cancer	0.00115	0.0018	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—germ cell cancer	0.00114	0.0018	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—germ cell cancer	0.00114	0.00179	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—germ cell cancer	0.00114	0.00179	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—germ cell cancer	0.00111	0.00175	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—germ cell cancer	0.00111	0.00175	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—germ cell cancer	0.0011	0.00173	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—germ cell cancer	0.0011	0.00173	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—germ cell cancer	0.00108	0.00169	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—germ cell cancer	0.00107	0.00169	CcSEcCtD
Brinzolamide—Rash—Cisplatin—germ cell cancer	0.00107	0.00168	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—germ cell cancer	0.00107	0.00168	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—germ cell cancer	0.00106	0.00167	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—germ cell cancer	0.00106	0.00166	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—germ cell cancer	0.00103	0.00161	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—germ cell cancer	0.00103	0.00161	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—germ cell cancer	0.00102	0.00161	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—germ cell cancer	0.00101	0.00158	CcSEcCtD
Brinzolamide—Cough—Methotrexate—germ cell cancer	0.000993	0.00156	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—germ cell cancer	0.000986	0.00155	CcSEcCtD
Brinzolamide—Rash—Etoposide—germ cell cancer	0.000978	0.00154	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—germ cell cancer	0.000977	0.00154	CcSEcCtD
Brinzolamide—Headache—Etoposide—germ cell cancer	0.000972	0.00153	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—germ cell cancer	0.000969	0.00152	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—germ cell cancer	0.000969	0.00152	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—germ cell cancer	0.000969	0.00152	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000962	0.00151	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—germ cell cancer	0.000957	0.00151	CcSEcCtD
Brinzolamide—Infection—Methotrexate—germ cell cancer	0.000923	0.00145	CcSEcCtD
Brinzolamide—Nausea—Etoposide—germ cell cancer	0.000921	0.00145	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—germ cell cancer	0.000911	0.00143	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—germ cell cancer	0.000902	0.00142	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—germ cell cancer	0.000868	0.00137	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000846	0.00133	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—germ cell cancer	0.00084	0.00132	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—germ cell cancer	0.000834	0.00131	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—germ cell cancer	0.000828	0.0013	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—germ cell cancer	0.000826	0.0013	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—germ cell cancer	0.000818	0.00129	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—germ cell cancer	0.000807	0.00127	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000802	0.00126	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—germ cell cancer	0.000801	0.00126	CcSEcCtD
Brinzolamide—Pain—Methotrexate—germ cell cancer	0.000794	0.00125	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—germ cell cancer	0.000765	0.0012	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—germ cell cancer	0.000738	0.00116	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—germ cell cancer	0.000684	0.00108	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—germ cell cancer	0.000666	0.00105	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—germ cell cancer	0.000657	0.00103	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—germ cell cancer	0.000636	0.001	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—germ cell cancer	0.000614	0.000966	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—germ cell cancer	0.000591	0.000929	CcSEcCtD
Brinzolamide—Rash—Methotrexate—germ cell cancer	0.000586	0.000921	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—germ cell cancer	0.000585	0.00092	CcSEcCtD
Brinzolamide—Headache—Methotrexate—germ cell cancer	0.000582	0.000915	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—germ cell cancer	0.000552	0.000868	CcSEcCtD
